LTC Properties Inc vs TransMedics Group Inc — how do they compare? LTC Properties Inc trades at $42.69 (market cap $2.27B), while TransMedics Group Inc trades at $78.42 (market cap $2.74B). The key difference: TransMedics Group Inc is the larger of the two by market cap, and LTC Properties Inc pays a 5.42% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold LTC Properties Inc for 88 Days and TransMedics Group Inc for 24 Days on average.
| LTC | TMDX | |
|---|---|---|
Market Cap | $2.27B | $2.74B |
Volume | 574,171 | 949,331 |
Sector | Real Estate | Health |
52-Week High | $43.50 | $150.42 |
52-Week Low | $33.98 | $61.99 |
Typical Hold Time | 88 Days | 24 Days |
Enterprise Value | $3.01B | $3.13B |
Dividend Yield | 5.42% | — |
Signals from Pluang's Aura AI — not financial advice
LTC Properties trades at $42.63, up 1.96% today, with mixed technical signals showing bearish overall momentum but bullish moving averages. The REIT maintains strong fundamentals with 38.93% net margins and consistent dividend payments of $0.19 monthly. Recent acquisitions totaling $160 million signal aggressive growth in seniors housing properties, though the stock faces resistance near $43.
Outlook remains cautiously optimistic with a $49.67 analyst price target suggesting 16% upside potential. Key opportunities include demographic tailwinds in senior care and portfolio transformation, while risks involve rising interest rates and execution challenges in SHOP segment expansion. The 31.82% buy rating reflects balanced Wall Street sentiment amid transition phase.
TransMedics Group (TMDX) trades at $78.17, down 3.58% on the day, with a bearish technical signal and mixed earnings history. The company reported strong 2025 results with $605.49M revenue and $190.29M net income, but 2026 projections show margin compression. Recent news highlights insider buying and leadership changes alongside legal investigations into fiduciary duties, creating a complex sentiment backdrop.
The stock offers growth potential with a consensus price target of $99.75, but faces risks from earnings misses, margin pressure, and ongoing legal scrutiny. Analyst consensus remains bullish with 69% buy ratings, yet investors must weigh robust profitability metrics against execution and regulatory uncertainties.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →